Quillaja saponaria, Vaccine adjuvant, EU GMP grade >95% size: 1 mg

Quillaja saponaria, Vaccine Adjuvant, EU GMP Grade >95% – 1 mg is a high-purity, plant-derived saponin used as a potent vaccine adjuvant to enhance immune responses and antigen presentation in preclinical and clinical research. This EU GMP-grade Quillaja saponaria extract ensures consistent quality, reproducibility, and safety for vaccine formulation, immunotherapy, and pharmaceutical studies. With purity exceeding 95% and supplied in a 1 mg size, it is ideal for small-scale experimental setups, adjuvant optimization, and immune modulation studies, providing robust stimulation of both humoral and cellular immunity. Perfect for laboratories and biotech companies focused on vaccine development, translational immunology, and immunogenicity enhancement, this high-grade saponin is an essential tool for regulatory-compliant adjuvant research.